Archana Wagle, MD
Interventional Pain Medicine · Rock Island, ILNPI 1366421968
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 38.3% of the total. Reporting peaked in 2021 at $587 and has fallen 86.9% since, to $77 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.
Across 27 payments — averaging $55.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$572
- Medtronic$300
- Boston Scientific$280
- Comsort, Inc$100
- Vertex$77
- Chiesi USA, Inc.$61
- plus $104 from 4 others
What the payments were for
- Consulting fees$1007%
- Speaking & faculty fees$55037%
- Travel & lodging$18012%
- Food & beverage$66344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 3 | $572 |
| Medtronic | 6 | $300 |
| Boston Scientific | 6 | $280 |
| Comsort, Inc | 1 | $100 |
| Vertex | 4 | $77 |
| Chiesi USA, Inc. | 1 | $61 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Abbott | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$550
- INTELLIS$159
- SPECTRA WAVEWRITER$108
- BRIDION$100
How this compares
$1,494 in reported general payments places this provider in the 45th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 55 | $14,563 |
| Lidocaine | 66 | $10,487 |
| Gabapentin | 332 | $6,127 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 327 | $4,872 |
| Duloxetine Hcl | 226 | $4,443 |
| Pregabalin | 113 | $2,680 |
| Tizanidine Hcl | 267 | $2,230 |
| Tramadol Hcl | 269 | $2,076 |
| Diclofenac Sodium | 29 | $1,751 |
| Baclofen | 165 | $1,644 |
| Cyclobenzaprine Hcl | 88 | $1,482 |
| Celecoxib | 115 | $1,375 |
| Fentanyl | 17 | $1,244 |
| Metaxalone | 13 | $1,052 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $689 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Rock Island
- Alexander FeoktistovNorthfield$922K
- Timothy LubenowChicago$556K
- Sandeep AminChicago$430K
- Matthew JaycoxChicago$123K
- Hong VoChicago$91K
- Asokumar BuvanendranChicago$52K
- Ramsin BenyaminBloomington$32K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
- Jay JoshiDeer Park$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.